Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Liver Neoplasms × Yttrium-90 × Clear all

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Liver Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Sorafenib 11 Radiosurgery 5 Gemcitabine 5 Capecitabine 5 Radiotherapy 4 Fluorouracil 4 Doxorubicin 4 Sunitinib 3 Oxaliplatin 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Bevacizumab 3 seocalcitol 2 regorafenib 2 phosphomannopentaose sulfate 2 atezolizumab 2 Thiotepa 2 Radiofrequency Ablation 2 Melphalan 2 Ifosfamide 2 Granulocyte Colony-Stimulating Factor 2 Fluorodeoxyglucose F18 2 Filgrastim 2 Dexamethasone 2 Cisplatin 2 Chemoembolization, Therapeutic 2 Carboplatin 2 Busulfan 2 Brachytherapy 2 voxilaprevir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02787954 2018-10-18

Liver

The University of Texas Health Science Center, Houston

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡